Oncology & Cancer

Novel method identifies the right individual exosomes

There is a growing demand for diagnostic markers for early disease detection and prognosis. Exosomes are potential biomarkers for cancer progression and neurodegenerative disease, but it can be difficult to identify what ...

Medical research

Microfluidics device helps diagnose sepsis in minutes

A novel sensor designed by MIT researchers could dramatically accelerate the process of diagnosing sepsis, a leading cause of death in U.S. hospitals that kills nearly 250,000 patients annually.

Neuroscience

Coenzyme Q10 study indicates promise in Huntington's treatment

A new study shows that the compound Coenzyme Q10 (CoQ) reduces oxidative damage, a key finding that hints at its potential to slow the progression of Huntington disease. The discovery, which appears in the inaugural issue ...

Neuroscience

New blood test could improve concussion diagnosis: Study

A global blood test for concussion could be a step closer after a Monash University-led study discovered specific proteins or biomarkers that can help diagnose concussions relatively quickly and accurately.

Alzheimer's disease & dementia

Panel of 48 CSF proteins complements existing Alzheimer biomarkers

A panel of 48 proteins in the cerebrospinal fluid (CSF 48 panel) complements existing CSF biomarkers for Alzheimer disease (AD), according to a study published in the Sept. 6 issue of Science Translational Medicine.

page 2 from 14